Idiopathic Pulmonary Fibrosis (IPF) is a chronic interstitial lung disease which results in end-
stage fibrosis. The pathogenesis is believed to be related to a dysregulation in cross-talk …

Idiopathic pulmonary fibrosis (IPF) is the most frequent fibrotic diffuse parenchymal lung
disease. Its prognosis is devastating:> 50% of the patients die within 3 years after diagnosis …

This month, September, is Pulmonary Fibrosis Awareness Month, and this year, 2020, will
be 36 forever remembered as the year that brought us COVID-19. Pulmonary fibrosis and …

Abstract Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal form of
interstitial lung disease. It is characterized by injury with loss of lung epithelial cells and …

Idiopathic pulmonary fibrosis (IPF) is a chronic and usually progressive lung disorder of
unknown aetiology. Conventional management of patients with IPF has been primarily …

Context.—Idiopathic pulmonary fibrosis is a uniformly lethal disease with limited biomarkers
and no proven therapeutic intervention short of lung transplantation. Pulmonary fibrosis at …

Molecular biomarkers are highly desired in idiopathic pulmonary fibrosis (IPF), where they
hold the potential to elucidate underlying disease mechanisms, accelerated drug …

Idiopathic pulmonary fibrosis is a progressive disease of unknown etiology characterized by
a dysregulated wound healing response that leads to fatal accumulation of fibroblasts and …

Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive form of lung disease of
unknown etiology for which a paucity of therapies suggest benefit, and for which none have …

Background Acute respiratory distress syndrome (ARDS) is the most severe manifestation of
acute lung injury (ALI). In patients who survive the acute injury the process of repair and …